The Biotech Tango: Why Merck Pumped the Brakes on Terns Pharmaceuticals' Acquisition
A New Horizon in Glaucoma Care: Bausch + Lomb's ELIOS System Shines in Pivotal Trial
Zevra Therapeutics: A High-Stakes Bet in the Ultra-Rare Disease Arena
Guardant Health Shares Plummet as Landmark Cancer Test Trial Fails to Meet Primary Endpoint